Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)

Capecitabine and temozolomide (CAPTEM) have shown promising results in the treatment of neuroendocrine neoplasms (NEN). The aim of this study was to evaluate the outcome and role for CAPTEM in malignant neuroendocrine neoplasms. Data were obtained from NEN patients who received at least one cycle of...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Katharine, Voros, Brianne A., Meadows-Taylor, Meghan, Smeltzer, Matthew P., Griffin, Ryan, Boudreaux, J. Philip, Thiagarajan, Ramcharan, Woltering, Eugene A., Ramirez, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017154/
https://www.ncbi.nlm.nih.gov/pubmed/31947598
http://dx.doi.org/10.3390/cancers12010206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017154/
https://www.ncbi.nlm.nih.gov/pubmed/31947598
http://dx.doi.org/10.3390/cancers12010206

Ejemplares similares